Connecting clinical outcomes to commissioning value
Dual
CEA and budget impact
Pathway-level
Modelling granularity
Stated
Uncertainty reporting
The challenge
A commissioner was considering a service redesign and needed to understand both its cost-effectiveness relative to current provision and its affordability within a fixed budget.
Our approach
- Synthesised clinical and cost evidence relevant to the proposed pathway.
- Built a cost-effectiveness model connecting clinical outcomes to economic value.
- Produced a separate budget impact analysis addressing affordability within the funding envelope.
- Stated the limitations of the underlying evidence plainly to support honest interpretation.
The outcome
The commissioner gained a defensible basis for a difficult resource decision, with a clear distinction between cost-effectiveness and affordability and a transparent account of the evidence behind each.
Health EconomicsQuantitative ResearchEconomic Consulting
Begin a conversation
Considering an engagement?
We work with a limited number of organisations at any one time. If you are weighing a decision that would benefit from independent analysis, we would welcome an early, confidential conversation.